Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Guido Grassi
The session "Hypertension and diabetes - deadly challenge" was devoted to an update on the treatment of hypertension in type 2 diabetic patients. Uncomplicated hypertension with diabetes: when and how to treat? Hypertension with diabetic nephropathy: how to manage? Two short presentations followed by two panelist discussions represented the core of the session. Three were the main messages developed. The first one was the blood pressure target for the antihypertensive intervention, with evidence that in order to obtain an effective cardiovascular risk reduction blood pressure should be reduced to values close to 130/80 mmHg. Lower values may be associated with the so called J-curve phenomenon, meaning an increase rather than a reduction of coronary events. The second issue refers to the need to use in diabetic hypertensive patients a two drug combination treatment in order to achieve an effective control of elevated blood pressure values. Finally, the third issue refers to the need to use a drug as a component of the two drug combination regimen acting on the renin-angiotensin system (Ace inhibitor or an angiotensin II receptor blocker) in order to achieve a greater nephroprotection, particularly when microalbuminuria is present. The session ended with a short presentation of the current European Society of Cardiology/European Society of Hypertension Guidelines on hypertension treatment. Guidelines were issued about two years ago and they are expected to be replaced by new guidelines in 2013.
Hypertension and diabetes - deadly challenge
© 2017 European Society of Cardiology. All rights reserved